pepi.ninja
Independent coverage of peptide research and FDA compounding policy.
We follow the U.S. Food and Drug Administration's review of bulk drug substances under the Pharmacy Compounding Advisory Committee and maintain a curated reference index of peptides discussed in the published literature. We do not sell, distribute, or endorse the use of any substance.
Subscribe to pepi.ninja
Independent coverage of peptide research and FDA compounding policy. Updates on PCAC meetings, new published studies, and regulatory developments.